# Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy

Study · id `cardio:ct-nct01121107` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01121107](<https://clinicaltrials.gov/study/NCT01121107>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01121107

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 486 participants.

## Technical summary

Registry record NCT01121107. Randomized; no masking; primary purpose diagnostic. Start 2010-04 (registry gives no type); primary completion 2015-04 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 486 participants (enrolled count; ClinicalTrials.gov record NCT01121107, source copy `cardio:ctgov-nct01121107-2023-07-21`, retrieved 2026-10-26)
- Start date: 2010-04 (registry gives no type) (ClinicalTrials.gov record NCT01121107, source copy `cardio:ctgov-nct01121107-2023-07-21`, retrieved 2026-10-26)
- Primary completion: 2015-04 (actual) (ClinicalTrials.gov record NCT01121107, source copy `cardio:ctgov-nct01121107-2023-07-21`, retrieved 2026-10-26)
- Completion: 2015-04 (actual) (ClinicalTrials.gov record NCT01121107, source copy `cardio:ctgov-nct01121107-2023-07-21`, retrieved 2026-10-26)
- Countries: United States; New Zealand (ClinicalTrials.gov record NCT01121107, source copy `cardio:ctgov-nct01121107-2023-07-21`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01121107-2023-07-21`, retrieved 2026-10-26)

## The registry's words

- Brief title: Left Atrial Pressure Monitoring to Optimize Heart Failure Therapy
- Acronym: LAPTOP-HF
- Condition: Heart Failure
- Intervention (Device): Left Atrial Pressure Monitoring System
- Intervention (Device): Patient Advisory Module
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: 5c180a5ed139b1401b63cf55e45dcd8835df08a9500c4dca6c70b75217c2e697
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
